Recce Pharmaceuticals Ltd.ASX: RCE

Phase I Clinical Trial of R327 I.V. - 6000mg Complete

Aug 22, 2022 at 2:24 AM UTC · Issued by Recce Pharmaceuticals Ltd.

Recce Ltd has released a press release.

View Attachment